{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T19:40:08Z","timestamp":1749325208390,"version":"3.41.0"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiomyopathy and causes changes in the cardiac muscle affecting ventricular, valvular, and cellular functions. Because HCM is an inherited disorder, all age groups are affected; however, it commonly presents in adolescents, especially athletes. Many patients are asymptomatic and undiagnosed, putting them at risk for sudden cardiac death. This article describes screening and management of patients with HCM.<\/jats:p>","DOI":"10.1097\/01.jaa.0000791464.54226.d8","type":"journal-article","created":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T03:00:10Z","timestamp":1632106810000},"page":"23-27","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Screening for hypertrophic cardiomyopathy"],"prefix":"10.1097","volume":"34","author":[{"given":"Sunayana C.","family":"Pydah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberlee","family":"Mauck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chelsea","family":"Shultis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenna","family":"Rolfs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joyce","family":"Nicholas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"8","key":"R2-20250607","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.amjcard.2017.12.043","article-title":"Is it fair to screen only competitive athletes for sudden death risk, or is it time to level the playing field","volume":"121","author":"Maron","year":"2018","journal-title":"Am J Cardiol"},{"issue":"14","key":"R3-20250607","doi-asserted-by":"crossref","first-page":"e012235","DOI":"10.1161\/JAHA.119.012235","article-title":"Performance of the American Heart Association (AHA) 14-point evaluation versus electrocardiography for the cardiovascular screening of high school athletes: a prospective study","volume":"8","author":"Williams","year":"2019","journal-title":"J Am Heart Assoc"},{"issue":"7","key":"R4-20250607","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1161\/CIRCRESAHA.117.311059","article-title":"Hypertrophic cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy","volume":"121","author":"Marian","year":"2017","journal-title":"Circ Res"},{"issue":"12","key":"R5-20250607","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jacc.2015.01.019","article-title":"New perspectives on the prevalence of hypertrophic cardiomyopathy","volume":"65","author":"Semsarian","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"R6-20250607","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1161\/CIRCULATIONAHA.106.644682","article-title":"Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction","volume":"114","author":"Maron","year":"2006","journal-title":"Circulation"},{"issue":"39","key":"R7-20250607","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur Heart J"},{"issue":"24","key":"R8-20250607","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1161\/CIR.0b013e318223e230","article-title":"2011 ACCF\/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary","volume":"124","author":"Gersh","year":"2011","journal-title":"Circulation"},{"key":"R10-20250607","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1136\/heartjnl-2020-317043","article-title":"Genetics of hypertrophic cardiomyopathy: what is the next step","volume":"106","author":"Kuusisto","year":"2020","journal-title":"Heart2020"},{"issue":"26","key":"R11-20250607","article-title":"Genetic testing in management of hypertrophic cardiomyopathy\u2014fifth in series","volume":"13","author":"Kacem","year":"2015","journal-title":"Council Cardiol Pract"},{"issue":"9","key":"R13-20250607","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11886-017-0897-z","article-title":"Complementary role of echocardiography and cardiac magnetic resonance in hypertrophic cardiomyopathy","volume":"19","author":"Hindieh","year":"2017","journal-title":"Curr Cardiol Rep"},{"author":"Mitevksa","key":"R14-20250607","article-title":"Focus on echocardiography in hypertrophic cardiomyopathy\u2014fourth in series"},{"key":"R15-20250607","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ejro.2019.01.007","article-title":"Cardiovascular magnetic resonance T2\u2217 mapping for structural alterations in hypertrophic cardiomyopathy","volume":"6","author":"Gastl","year":"2019","journal-title":"Eur J Radiol Open"},{"issue":"15","key":"R16-20250607","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1161\/CIR.0000000000000025","article-title":"Assessment of the 12-lead ECG as a screening test for detection of cardiovascular disease in healthy general populations of young people (12\u201325 years of age)","volume":"130","author":"Maron","year":"2014","journal-title":"Circulation"},{"issue":"14","key":"R17-20250607","doi-asserted-by":"crossref","first-page":"e013007","DOI":"10.1161\/JAHA.119.013007","article-title":"There is no reason to adopt ECGs and abandon American Heart Association\/American College of Cardiology history and physical screening for detection of cardiovascular disease in the young","volume":"8","author":"Maron","year":"2019","journal-title":"J Am Heart Assoc"},{"issue":"45","key":"R18-20250607","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1093\/eurheartj\/ehz396","article-title":"Family screening for hypertrophic cardiomyopathy: is it time to change practice guidelines","volume":"40","author":"Lafreniere-Roula","year":"2019","journal-title":"Eur Heart J"},{"issue":"6","key":"R19-20250607","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.7863\/ultra.16.06044","article-title":"Hypertrophic cardiomyopathy in youth athletes: successful screening with point-of-care ultrasound by medical students","volume":"36","author":"Fox","year":"2017","journal-title":"J Ultrasound Med"},{"issue":"25","key":"R20-20250607","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1016\/j.jacc.2020.08.045","article-title":"2020 AHA\/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"76","author":"Ommen","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"R21-20250607","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1161\/CIRCRESAHA.116.309348","article-title":"Hypertrophic obstructive cardiomyopathy: surgical myectomy and septal ablation","volume":"121","author":"Nishimura","year":"2017","journal-title":"Circ Res"},{"issue":"38","key":"R22-20250607","article-title":"MRI in the diagnosis of hypertrophic cardiomyopathy. European Society of Cardiology","volume":"4","author":"Lombardi","year":"2006","journal-title":"J Cardiol Pract"},{"issue":"suppl 4","key":"R23-20250607","doi-asserted-by":"crossref","first-page":"39S","DOI":"10.2967\/jnumed.114.142729","article-title":"Role of cardiac MR imaging in cardiomyopathies","volume":"56","author":"Kramer","year":"2015","journal-title":"J Nucl Med"},{"issue":"3","key":"R24-20250607","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.csm.2015.03.005","article-title":"Sports and exercise in athletes with hypertrophic cardiomyopathy","volume":"34","author":"Alpert","year":"2015","journal-title":"Clin Sports Med"},{"issue":"1","key":"R25-20250607","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ccl.2018.08.004","article-title":"Lifestyle modification and medical management of hypertrophic cardiomyopathy","volume":"37","author":"Heitner","year":"2019","journal-title":"Cardiol Clin"},{"issue":"12","key":"R26-20250607","doi-asserted-by":"crossref","first-page":"e007161","DOI":"10.1161\/JAHA.117.007161","article-title":"Impact of demographic features, lifestyle, and comorbidities on the clinical expression of hypertrophic cardiomyopathy","volume":"6","author":"Finocchiaro","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"12","key":"R28-20250607","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.echo.2016.09.006","article-title":"Impact of afterload increase on left ventricular myocardial deformation indices","volume":"29","author":"Reant","year":"2016","journal-title":"J Am Soc Echocardiogr"},{"issue":"2 suppl 1","key":"R29-20250607","first-page":"143","article-title":"Focus on periodontal disease and development of endocarditis","volume":"32","author":"Carinci","year":"2018","journal-title":"J Biol Regul Homeost Agents"},{"issue":"3","key":"R30-20250607","first-page":"33","article-title":"Follow-up and prognosis of HCM","volume":"2018","author":"Dominguez","year":"2018","journal-title":"Glob Cardiol Sci Pract"},{"issue":"22","key":"R31-20250607","first-page":"5207","article-title":"Review of recent advances in the management of hypertrophic cardiomyopathy","volume":"21","author":"Cao","year":"2017","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"4","key":"R32-20250607","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3909\/ricm0546","article-title":"Medical management of hypertrophic cardiomyopathy","volume":"11","author":"Naghi","year":"2010","journal-title":"Rev Cardiovasc Med"},{"issue":"7","key":"R33-20250607","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1056\/NEJMra1710575","article-title":"Clinical course and management of hypertrophic cardiomyopathy","volume":"379","author":"Maron","year":"2018","journal-title":"N Engl J Med"},{"issue":"5","key":"R34-20250607","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/2211-5463.12416","article-title":"Synergistic effects of HMG-CoA reductase inhibitor and angiotensin II receptor blocker on load-induced heart failure","volume":"8","author":"Ito","year":"2018","journal-title":"FEBS Open Bio"},{"issue":"3","key":"R35-20250607","first-page":"31","article-title":"Implantable cardioverter-defibrillator in hypertrophic cardiomyopathy","volume":"2018","author":"Sanchez","year":"2018","journal-title":"Glob Cardiol Sci Pract"},{"issue":"3","key":"R36-20250607","doi-asserted-by":"crossref","first-page":"e219","DOI":"10.1016\/j.crvasa.2015.02.003","article-title":"Medical treatment of hypertrophic cardiomyopathy\u2014what do we know about it today","volume":"57","author":"Gregor","year":"2015","journal-title":"Cor et Vasa"},{"issue":"6","key":"R37-20250607","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1161\/CIRCULATIONAHA.118.038436","article-title":"Evaluating and reducing the risk of sudden death in hypertrophic cardiomyopathy","volume":"139","author":"Udelson","year":"2019","journal-title":"Circulation"},{"issue":"10","key":"R38-20250607","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1016\/j.jacc.2004.04.063","article-title":"The case for surgery in obstructive hypertrophic cardiomyopathy","volume":"44","author":"Maron","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"10 Pt 2","key":"R39-20250607","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1111\/j.1540-8159.1997.tb06120.x","article-title":"Arrhythmias in hypertrophic cardiomyopathy","volume":"20","author":"Kuck","year":"1997","journal-title":"Pacing Clin Electrophysiol"},{"issue":"21","key":"R40-20250607","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1161\/CIRCULATIONAHA.119.040271","article-title":"Hypertrophic cardiomyopathy-related sudden cardiac death in young people in Ontario","volume":"140","author":"Weissler-Snir","year":"2019","journal-title":"Circulation"}],"container-title":["JAAPA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.JAA.0000791464.54226.d8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T19:00:45Z","timestamp":1749322845000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/01.JAA.0000791464.54226.d8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":36,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/01.jaa.0000791464.54226.d8","relation":{},"ISSN":["1547-1896"],"issn-type":[{"type":"print","value":"1547-1896"}],"subject":[],"published":{"date-parts":[[2021,10]]}}}